Format

Send to

Choose Destination
Cutis. 2005 Aug;76(2):129-32.

Treatment of severe, recalcitrant, major aphthous stomatitis with adalimumab.

Author information

1
Department of Dermatology, University of Pittsburgh Physicians, Pennsylvania, USA.

Abstract

We describe an 18-year-old man with a 7-year history of severe major aphthous stomatitis refractory to multiple standard therapies who responded completely to therapy with adalimumab, a fully humanized monoclonal antibody against tumor necrosis factor alpha (TNF-alpha).

PMID:
16209159
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center